Do corticosteroids damage the brain?

Journal of Neuroendocrinology

Volumn 18, Issue 6, 2006, Pages 393-411

  Herbert, Joe ^a   Goodyer, I M ^b   Grossman, A B ^c   Hastings, M H ^d   de Kloet, E R ^e   Lightman, S L ^f   Lupien, S J ^g   Roozendaal, B ^h   Seckl, J R ⁱ  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Amygdala; Brain damage; Corticoids; Cushing's syndrome; Hippocampus; Memory; Rhythms

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; GLUCOCORTICOID ANTAGONIST; HYDROCORTISONE; METYRAPONE; N METHYL DEXTRO ASPARTIC ACID; PRASTERONE; PREDNISOLONE; SEROTONIN UPTAKE INHIBITOR; VASOPRESSIN;

ADDISON DISEASE; ADULTHOOD; AGE DISTRIBUTION; AGING; AMYGDALOID NUCLEUS; BRAIN DAMAGE; BRAIN DYSFUNCTION; BRAIN FUNCTION; CIRCADIAN RHYTHM; CORTICOSTEROID BLOOD LEVEL; CORTICOSTEROID RELEASE; CUSHING SYNDROME; DEPRESSION; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LONG TERM EXPOSURE; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINE SYSTEM; NONHUMAN; NORMAL VALUE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STEROID RELEASE; STRESS; SYSTEMATIC REVIEW; TISSUE LEVEL;

ADRENAL CORTEX HORMONES; ANIMALS; BRAIN CHEMISTRY; CUSHING SYNDROME; HUMANS;

EID: 33646378403     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01429.x     Document Type: Review

References (204)

1. Netherton C, Goodyer I, Tamplin A, Herbert J. Salivary cortisol and dehydroepiandrosterone in relation to puberty and gender. Psychoneuroendocrinology 2004; 29: 125-140.
2. Selye H. Stress and the general adaptation syndrome. Br Med J 1950; 4667: 1383-1392.
3. Selye H. Stress and distress. Compr Ther 1975; 1: 9-13.
4. Dallman MF, Akana SF, Strack AM, Scribner KS, Pecoraro N, La Fleur SE, Houshyar H, Gomez F. Chronic stress-induced effects of corticosterone on brain: Direct and indirect. Ann NY Acad Sci 2004; 1018: 141-150.
5. Jones BC, Sarrieau A, Reed CL, Azar MR, Mormede P. Contribution of sex and genetics to neuroendocrine adaptation to stress in mice. Psychoneuroendocrinology 1998; 23: 505-517.
6. Stohr T, Schulte Wermeling D, Szuran T, Pliska V, Domeney A, Welzl H, Weiner I, Feldon J. Differential effects of prenatal stress in two inbred strains of rats. Pharmacol Biochem Behav 1998; 59: 799-805.
7. Grota LJ, Bienen T, Felten DL. Corticosterone responses of adult Lewis and Fischer rats. J Neuroimmunol 1997; 74: 95-101.
8. Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: A review of the literature. Clin Endocrinol (Oxf) 2005; 63: 483-492.
9. Windle RJ, Wood SA, Lightman SL, Ingram CD. The pulsatile characteristics of hypothalamo-pituitary-adrenal activity in femnale Lewis and Fischer 344 rats and it's relationship to differential stress responses. Endocrinology 1998; 139: 4044-4052.
10. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD. Ultradian rhythm of basal corticosterone release in the female rat: Dynamic interaction with the response to acute stress. Endocrinology 1998; 139: 443-450.
11. Young EA, Abelson J, Lightman SL. Cortisol pulsatility and its role in stress regulation and health. Front Neuroendocrinol 2004; 25: 69-76.
12. Hastings MH, Reddy AB, Maywood ES. A clockwork web. circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003; 4: 649-661.
13. Dey J, Carr AJ, Cagampang FR, Semikhodskii AS, Loudon AS, Hastings MH, Maywood ES. The tau mutation in the Syrian hamster differentially reprograms the circadian clock in the SCN and peripheral tissues. J Biol Rhythms 2005; 20: 99-110.
14. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu YH. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001; 291: 1040-1043.
15. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935-941.
16. Buijs RM, Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2001; 2: 521-526.
17. Saper CB, Cano G, Scammell TE. Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol 2005; 493: 92-98.
18. Kalsbeek A, van Heerikhuize JJ, Wortel J, Buijs RM. A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J Neurosci 1996; 16: 5555-5565.
19. Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J, Weaver DR, Leslie F, Zhou QY. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2001; 417: 405-410.
20. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003; 24: 151-180.
21. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, Schutz G, Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000; 289: 2344-2347.
22. Hastings MH. Circadian clockwork: Two loops are better than one. Nat Rev Neurosci 2000; 1: 143-146.
23. Hatfield CF, Herbert J, van Someren EJ, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004; 127: 1061-1074.
24. Ribeiro SC, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: A meta-analysis. Am J Psychiatry 1993; 150: 1618-1629.
25. Charles GA, Schittecatte M, Rush AJ, Panzer M, Wilmotte J. Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. J Affect Disord 1989; 17: 271-278.
26. Lightman SL, Windle RJ, Julian MD, Harbuz MS, Shanks N, Wood SA, Kershaw YM, Ingram CD. Pulsatlie secretion alters with ageing. In: Veldhuis JD, eds. Mechanisms and Significance of Pulsatile Hormone Secretion. Chichester: John Wiley, 1999: 244-260.
27. Dettling AC, Gunnar MR, Donzella B. Cortisol levels of young children in full-day childcare centers: Relations with age and temperament. Psychoneuroendocrinology 1999; 24: 519-536.
28. Lupien S, Lecours AR, Schwartz G, Sharma S, Hauger RL, Meaney MJ, Nair NP. Longitudinal study of basal cortisol levels in healthy elderly subjects: Evidence for subgroups. Neurobiol Aging 1996; 17: 95-105.
29. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: Relation to blood levels and the effects of age. J Clin Endocrinol Metab 1996; 81: 3951-3960.
30. Seale JV, Wood SA, Atkinson HC, Harbuz MS, Lightman SL. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J Neuroendocrinol 2004; 16: 989-998.
31. Seale JV, Wood SA, Atkinson HC, Lightman SL, Harbuz MS. Organizational role for testosterone and estrogen on adult hypothalamic-pituitary-adrenal axis activity in the male rat. Endocrinology 2005; 146: 1973-1982.
32. Linkowski P, Van Onderbergen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E. Twin study of the 24-h cortisol profile: Evidence for genetic control of the human circadian clock. Am J Physiol 1993; 264: E173-E181.
33. Wust S, Federenko I, Hellhammer DH, Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000; 25: 707-720.
34. van Rossum EF, Koper JW, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, Grobbee DE, de Jong FH, van Duyn CM, Pols HA, Lamberts SW. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 2002; 51: 3128-3134.
35. van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, Kemper HC, Lamberts SW. The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 2004; 89: 4004-4009.
36. Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CE, Donn R. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab 2004; 89: 892-897.
37. Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, Lamberts SW, Koper JW. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 2005; 90: 5084-5810.
38. Wust S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH 2004 Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2005; 89: 565-573.
39. Alesci S, De Martino MU, Ilias I, Gold PW, Chrousos GP. Glucocorticoid-induced osteoporosis: From basic mechanisms to clinical aspects. Neuroimmunomodulation 2005; 12: 1-19.
40. Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De Nicola AF, Baulieu EE. Steroid synthesis and metabolism in the nervous system. trophic and protective effects. J Neurocytol 2000; 29: 307-326.
41. Goodyer IM, Herbert J, Tamplin A, Altham PM. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br J Psychiatry 2000; 177: 499-504.
42. Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metabol 2004; 89: 281-287.
43. Viau V, Meaney MJ. Testosterone-dependent variations in plasma and intrapituitary corticosteroid binding globulin and stress hypothalamic-pituitary-adrenal activity in the male rat. J Endocrinol 2004; 181: 223-231.
44. Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001; 142: 2686-2694.
45. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998; 139: 1789-1793.
46. Herbert J. Peptides in the limbic system: Neurochemical codes for co-ordinated adaptive responses to behavioural and physiological demand. Prog Neurobiol 1993; 41: 723-791.
47. Selye H. The evolution of the stress concept. Am Sci 1973; 61: 692-699.
48. Munck A, Naray-Fejes-Toth A. Glucocorticoids and stress. permissive and suppressive actions. Ann NY Acad Sci 1994; 746: 115-130.
49. Martensz ND, Vellucci SV, Fuller LM, Everitt BJ, Keverne EB, Herbert J. Relation between aggressive behaviour and circadian rhythms in cortisol and testosterone in social groups of talapoin monkeys. J Endocrinol 1987; 115: 107-120.
50. Abbott DH, Keverne EB, Bercovitch FB, Shively CA, Mendoza SP, Saltzman W, Snowdon CT, Ziegler TE, Banjevic M, Garland TJ, Sapolsky RM. Are subordinates always stressed? A comparative analysis of rank differences in cortisol levels among primates. Hormones Behav 2003; 43: 67-82.
51. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology 1992; 130: 1394-1400.
52. Ma XM, Lightman SL. The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats. J Physiol (Lond) 1998; 510: 605-614.
53. Pinnock SB, Herbert J. Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress. Eur J Neurosci 2001; 13: 576-584.
54. Lightman SL, Young WS III. Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc Natl Acad Sci USA 1989; 86: 4306-4310.
55. Shanks N, Windle RJ, Perks P, Wood S, Ingram CD, Lightman SL. The hypothalamic-pituitary-adrenal axis response to endotoxin is attenuated during lactation. J Neuroendocrinol 1999; 11: 857-865.
56. Moisan MP, Seckl JR, Edwards CR. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain. localization in hypothalamus, hippocampus, and cortex. Endocrinology 1990; 127: 1450-1455.
57. Sandeep TC, Yau JL, MacLullich AM, Noble J, Deary IJ, Walker BR, Seckl JR. 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci USA 2004; 101: 6734-6739.
58. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 1997; 94: 14924-14929.
59. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004; 53: 931-938.
60. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: Analysis of 11beta-HSD-1-deficient mice. Endocrinology 2001; 142: 114-120.
61. Yau JL, Noble J, Kenyon CJ, Hibberd C, Kotelevtsev Y, Mullins JJ, Seckl JR. Lack of tissue glucocorticoid reactivation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci USA 2001; 98: 4716-4721.
62. Holmes MC, Yau JL, Kotelevtsev Y, Mullins JJ, Seckl JR. 11 Beta-hydroxysteroid dehydrogenases in the brain: Two enzymes two roles. Ann NY Acad Sci 2003; 1007: 357-366.
63. Seckl JR, Walker BR. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: From metabolism to memory. Trends Endocrinol Metabol 2004; 15: 418-421.
64. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985; 117: 2505-2511.
65. Seckl JR, Walker BR. 11β-hydroxysteoid dehydrogenase type 1 as a modulator of glucocorticoid action: From metabolism to memory. Trends Endocrinol Metabol 2004; 15: 418-424.
66. Seckl JR. 11beta-hydroxysteroid dehydrogenases: Changing glucocorticoid action. Curr Opin Pharmacol 2004; 4: 597-602.
67. Holmes MC, Sangra M, French KL, Whittle IR, Paterson J, Mullins JJ, Seckl JR. 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neuroscience 2005; 137: 865-873.
68. Levitt NS, Lindsay RS, Holmes MC, Seckl JR 1996 Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 2005; 64: 412-418.
69. Kaufer D, Ogle WO, Pincus ZS, Clark KL, Nicholas AC, Dinkel KM, Dumas TC, Ferguson D, Lee AL, Winters MA, Sapolsky RM. Restructuring the neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci 2004; 7: 947-953.
70. De Kloet ER. Brain corticosteroid balance and homeostatic control. Frontiers Neuroendocrinol 1991; 12: 95-164.
71. Hayashi R, Wada H, Ito K, Adcock IM. Effects of glucocorticoids on gene transcription. Eur J Pharmacol 2004; 500: 51-62.
72. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998; 76: 480-489.
73. Meijer OC, Kalkhoven E, van der Laan S, Steenbergen PJ, Houtman SH, Dijkmans TF, Pearce D, de Kloet ER. Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 2005; 146: 1438-1448.
74. Stromberg J, Backstrom T, Lundgren P 2005 Rapid non-genomic effect of glucocorticoid metabolites and neurosteroids on the gamma-aminobutyric acid-A receptor. Eur J Neurosci 2006; 21: 2083-2085.
75. Pretorius E, Marx J. Direct and indirect effects of corticosteroids on astrocyte function. Rev Neurosci 2004; 15: 199-207.
76. Cameron HA, Tanapat P, Gould E. Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neuroscience 1998; 82: 349-354.
77. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005; 30: 225-242.
78. Halligan SL, Herbert J, Goodyer IM, Murray L. Exposure to postnatal depression predicts elevated cortisol in adolescent offspring. Biol Psychiatry 2004; 55: 376-381.
79. Bremner JD, Vythilingam M, Vermetten E, Anderson G, Newcomer JW, Charney DS. Effects of glucocorticoids on declarative memory function in major depression. Biol Psychiatry 2004; 55: 811-815.
80. Liu D, Diorio J, Day JC, Francis DD, Meaney MJ. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci 2000; 3: 799-806.
81. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988; 239: 766-768.
82. Meaney MJ, Diorio J, Francis D, Widdowson J, LaPlante P, Caldji C, Sharma S, Seckl JR, Plotsky PM. Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for adrenocortical responses to stress. Dev Neurosci 1996; 18: 49-72.
83. Owen D, Andrews MH, Matthews SG. Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev 2005; 29: 209-226.
84. Oitzl MS, Workel JO, Fluttert M, Frosch F, de Kloet ER. Maternal deprivation affects behaviour from youth to senescence: Amplification of individual differences in spatial learning and memory in senescent Brown Norway rats. Eur J Neurosci 2000; 12: 3771-3780.
85. Jordan TC, Coe CL, Patterson J, Levine S. Predictability and coping with separation in infant squirrel monkeys. Behav Neurosci 1984; 98: 556-560.
86. Landfield PW, McEwan BS, Sapolsky RM, Meaney MJ. Hippocampal cell death. Science 1996; 272: 1249-1251.
87. Shanks N, Windle RJ, Perks PA, Harbuz MS, Jessup DS, Ingram CD, Lightman SL. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci USA 2000; 97: 5645-5650.
88. Seckl JR, Meaney MJ. Glucocorticoid programming. Ann NY Acad Sci 2004; 1032: 63-84.
89. de Kloet RR, Sibug RM, Helmerhorst FM, Schmidt M. Stress, genes and the mechanism of programming the brain for later life. Neurosci Biobehav Rev 2005; 29: 271-281.
90. McCormick JA, Lyons V, Jacobson MD, Noble J, Diorio J, Nyirenda M, Weaver S, Ester W, Yau JL, Meaney MJ, Seckl JR, Chapman KE. 5′-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: Differential regulation of variant transcripts by early-life events. Mol Endocrinol 2000; 14: 506-517.
91. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7: 847-854.
92. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004; 151 (Suppl. 3): U49-U62.
93. Dean F, Yu C, Lingas RI, Matthews SG. Prenatal glucocorticoid modifies hypothalamo-pituitary-adrenal regulation in prepubertal guinea pigs. Neuroendocrinology 2001; 73: 194-202.
94. Bhatnagar S, Lee TM, Vining C. Prenatal stress differentially affects habituation of corticosterone responses to repeated stress in adult male and female rats. Horm Behav 2005; 47: 430-438.
95. Kapoor A, Matthews SG. Short periods of prenatal stress affect growth, behaviour and hypothalamo-pituitary-adrenal axis activity in male guinea pig offspring. J Physiol 2005; 566: 967-977.
96. Morley-Fletcher S, Darnaudery M, Koehl M, Casolini P, Van Reeth O, Maccari S. Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res 2003; 989: 246-251.
97. Welberg LA, Seckl JR, Holmes MC. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001; 104: 71-79.
98. Nyirenda MJ, Welberg LA, Seckl JR. Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids-fetal effect or maternal influence? J Endocrinol 2001; 170: 653-660.
99. Cushing BS, Kramer KM. Mechanisms underlying epigenetic effects of early social experience. the role of neuropeptides and steroids. Neurosci Biobehav Rev 2005; 29: 1089-1105.
100. Yehuda R, Engel SM, Brand SR, Seckl J, Marcus SM, Berkowitz GS. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab 2005; 90: 4115-4118.
101. Lupien SJ, King S, Meaney MJ, McEwen BS. Child's stress hormone levels correlate with mother's socioeconomic status and depressive state. Biol Psychiatry 2000; 48: 976-980.
102. Lupien SJ, King S, Meaney MJ, McEwen BS. Can poverty get under your skin? Basal cortisol levels and cognitive function in children from low and high socioeconmoic status. Dev Psychopathol 2001; 13: 651-674.
103. Gutteling BM, de Weerth C, Buitelaar JK. Prenatal stress and children's cortisol reaction to the first day of school. Psychoneuroendocrinology 2005; 30: 541-549.
104. Goodyer IM, Herbert J, Tamplin A. Psychoendocrine antecedents of persistent first-episode major depression in adolescents: A community-based longitudinal enquiry. Psychol Med 2003; 33: 601-610.
105. Harris TO, Borsanyi S, Messari S, Stanford K, Cleary SE, Shiers HM, Brown GW, Herbert J. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br J Psychiatry 2000; 177: 505-510.
106. Kirschbaum C, Prussner J, Stone AA, Federenko I, Gaab J, Lintz D, Schommer N, Hellhammer DH. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosomat Med 1995; 57: 468-474.
107. Pruessner JC, Lord C, Meaney M, Lupien S. Effects of self-esteem on age-related changes in cognition and the regulation of the hypothalamic-pituitary-adrenal axis. Ann NY Acad Sci 2004; 1032: 186-194.
108. Pruessner JC, Baldwin MW, Dedovic K, Renwick R, Mahani NK, Lord C, Meaney M, Lupien S. Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood. Neuroimage 2005; 28: 815-826.
109. Teasdale JD 1993 Emotion and two kinds of meaning: Cognitive therapy and applied cognitive science. Behav Res Ther 2005; 31: 339-354.
110. Kelvin RG, Goodyer IM, Teasdale JD, Brechin D. Latent negative self-schema and high emotionality in well adolescents at risk for psychopathology. J Child Psychol Psychiatry 1999; 40: 959-968.
111. Friedman M, Green MF, Sharland D. Assessment of hypothalamic-pituitary-adrenal function in the geriatric age group. J Gerontol 1969; 24: 292-297.
112. Touitou Y, Sulon J, Bogdan A, Touitou C, Reinberg A, Beck H, Sodoyez JC, Demey-Ponsart E, VanCauwenberge A. Adrenal circadian system in young and elderly human subjects: A comparative study. J Endocrinol 1982; 93: 201-210.
113. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NP, Meaney MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994; 14: 2893-2903.
114. Landfield PW, Waymire JC, Lynch G. Hippocampal aging and adrenocorticoids: Quantitative correlations. Science 1978; 202: 1098-1102.
115. Lupien SJ, Wilkinson CW, Briere S, Ng Ying Kin NM, Meaney MJ, Nair NP. Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J Clin Endocrinol Metabol 2002; 87: 3798-3807.
116. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metabol 1992; 75: 1002-1004.
117. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 1998; 95: 1852-1857.
118. Kimonides VG, Spillantini MG, Sofroniew MV, Fawcett JW, Herbert J. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 1999; 89: 429-436.
119. Sapolsky RM. Glucocorticoid toxicity in the hippocampus. Temporal aspects of synergy with kainic acid. Neuroendocrinology 1986; 43: 440-444.
120. Tombaugh GC, Sapolsky RM. Corticosterone accelerates hypoxia- and cyanide-induced ATP loss in cultured hippocampal astrocytes. Brain Res 1992; 588: 154-158.
121. McKittrick CR, Magarinos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 2000; 36: 85-94.
122. Magarinos AM, Orchinik M, McEwen BS. Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: A paradox. Brain Res 1998; 809: 314-318.
123. Van Eekelen JA, De Kloet ER. Co-localization of brain corticosteroid receptors in the rat hippocampus. Prog Histochem Cytochem 1992; 26: 250-258.
124. Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain. an immunohistochemical and in situ hybridization study. Neurosci Res 1996; 26: 235-269.
125. Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005; 28: 223-250.
126. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965; 124: 319-335.
127. Shors TJ. Can new neurons replace memories lost? Sci Aging Knowledge Environ 2003; 49: 35.
128. Gould E, Tanapat P, Hastings NB, Shors TJ 1999 Neurogenesis in adulthood: A possible role in learning. Trends Cogn Sci 2003; 3: 186-192.
129. Cameron HA, Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994; 61: 203-209.
130. Gould E, Cameron HA, Daniels DC, Woolley CS, McEwen BS. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci 1992; 12: 3642-3650.
131. Wong EY, Herbert J. The corticoid environment: A determining factor for neural progenitors' survival in the adult hippocampus. Eur J Neurosci 2004; 20: 2491-2498.
132. Wong EY, Herbert J. Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus. Eur J Neurosci 2005; 22: 785-792.
133. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
134. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-809.
135. Holmes MC, Yau JL, French KL, Seckl JR. The effect of adrenalectomy on 5-hydroxytryptamine and corticosteroid receptor subtype messenger RNA expression in rat hippocampus. Neuroscience 1995; 64: 327-337.
136. Joels M, Karst H, Alfarez D, Heine VM, Qin Y, van Riel E, Verkuyl M, Lucassen PJ, Krugers HJ. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004; 7: 221-231.
137. Huang GJ, Herbert J. Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult rat. Neuropsychopharmacology 2005; 30: 231-241.
138. Sachar EJ. Evidence for neuroendocrine abnormalities in the major mental illnesses. Res Pub Assoc Res Nerv Ment Dis 1975; 54: 347-358.
139. Hallonquist JD, Goldberg MA, Brandes JS. Affective disorders and circadian rhythms. Can J Psychiatry 1986; 31: 259-272.
140. Huang G-J, Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 2006; 59: 619-624.
141. Cahill L, Weinberger NM, Roozendaal B, McGaugh JL 1999 Is the amygdala a locus of 'conditioned fear'? Some questions and caveats. Neuron 2006; 23: 227-228.
142. Maren S, Fanselow MS. The amygdala and fear conditioning: Has the nut been cracked? Neuron 1996; 16: 237-240.
143. McGaugh JL. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neuroscence 2004; 27: 1-28.
144. Roozendaal B, McGaugh JL. Basolateral amygdala lesions block the memory-enhancing effect of glucocorticoid administration in the dorsal hippocampus of rats. Eur J Neurosci 1997; 9: 76-83.
145. Roozendaal B, McGaugh JL. Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage. Neurobiol Learn Mem 1997; 67: 176-179.
146. Maheu FS, Joober R, Beaulieu S, Lupien SJ. Differential effects of adrenergic and corticosteroid hormonal systems on human short- and long-term declarative memory for emotionally arousing material. Behav Neurosci 2004; 118: 420-428.
147. Quirarte GL, Roozendaal B, McGaugh JL. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 1997; 94: 14048-14053.
148. Liang KC, Chen LL, Huang TE. The role of amygdala norepinephrine in memory formation: Involvement of memory enhancing effect of peripheral epinephrine. Chinese J Physiol 1995; 38: 81-91.
149. Williams CL, Men D, Clayton EC, Gold PE. Norepinephrine release in the amygdala following systemic injection of epinephrine or escapable foot shock: Contribution of the nucleus of the solitary tract. Behav Neurosci 1998; 112: 1414-1422.
150. Buchanan TW, Lovallo WR. Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 2001; 26: 307-317.
151. Oitzl MS, Reichardt HM, Joels M, de Kloet ER. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci USA 2001; 98: 12790-12795.
152. Lupien SJ, Wilkinson CW, Briere S, Menard C, Ng Ying Kin NM, Nair NP. The modulatory effects of corticosteroids on cognition: Studies in young human populations. Psychoneuroendocrinology 2002; 27: 401-416.
153. de Kloet ER, Oitzl MS, Joels M. Stress and cognition: Are corticosteroids good or bad guys? Trends Neurosci 1999; 22: 422-426.
154. Diamond DM, Bennett MC, Fleshner M, Rose G. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 1992; 2: 421-430.
155. Dubrovsky BO, Liquornik MS, Noble P, Gijsbers K. Effects of 5 alpha-dihydrocorticosterone on evoked responses and long-term potentiation. Brain Res Bull 1987; 19: 635-638.
156. Pavlides C, Watanabe Y, McEwen BS. Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus 1993; 3: 183-192.
157. Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 2002; 3: 453-462.
158. Tytherleigh MY, Vedhara K, Lightman SL. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease. Psychoneuroendocrinology 2004; 29: 712-723.
159. Kim JJ, Lee HJ, Han JS, Packard MG. Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J Neurosci 2001; 21: 5222-5228.
160. de Quervain DJ, Roozendaal B, McGaugh JL. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998; 394: 787-790.
161. Roozendaal B, McReynolds JR, McGaugh JL. The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci 2004; 24: 1385-1392.
162. Roozendaal B, Quirarte GL, McGaugh JL. Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor-cAMP/PKA system in influencing memory consolidation. Eur J Neurosci 2002; 15: 553-560.
163. Oitzl MS, de Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 1992; 106: 62-71.
164. Kuhlmann S, Kirschbaum C, Wolf OT. Effects of oral cortisol treatment in healthy young women on memory retrieval of negative and neutral words. Neurobiol Learn Mem 2005; 83: 158-162.
165. Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, McEwen BS, Meaney MJ. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 1999; 10: 117-139.
166. McDonald AJ. Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 1991; 44: 1-14.
167. Bechara A, Damasio H, Damasio AR, Lee GP. Different contribution of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 1999; 19: 5473-5481.
168. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 1994; 14: 2047-2053.
169. Dolan RJ, Fletcher PC. Dissociating prefrontal and hippocampal function in episodic memory encoding. Nature 1997; 388: 582-585.
170. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Distribution of corticosteroid receptors in the rhesus brain: Relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 2000; 20: 4657-4668.
171. Lupien SJ, Wilkinson CW, Briere S. Ng Ying Kin NM, Meaney MJ, Nair NP. Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J Clin Endocrinol Metab 2002; 87: 3798-3807.
172. Davidson JR, Stein DJ, Shalev AY, Yehuda R. Posttraumatic stress disorder. acquisition, recognition, course, and treatment. J Neuropsychiatry Clin Neurosci 2004; 16: 135-147.
173. Yehuda R. Hypothalamic-pituitary-adrenal alterations in PTSD. are they relevant to understanding cortisol alterations in cancer? Brain Behav Immun 2003; 17 (Suppl. 1): S73-S83.
174. Schelling G, Roozendaal B, De Quervain DJ. Can posttraumatic stress disorder be prevented with glucocorticoids? Ann NY Acad Sci 2004; 1032: 158-166.
175. Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, Nitsch RM, Schnyder U, de Quervain DJ. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 2004; 161: 1488-1490.
176. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK. Smaller hippocampal Volume predicts pathologic vulnerability to psychological trauma. Nature Neurosci 2002; 5: 1111-1113.
177. Giedd JN, Vaituzis AC, Hamburger SD, Lange N, Rajapakse JC, Kaysen D, Vauss YC, Rapoport JL. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: Ages 4-18 years. J Comp Neurol 1996; 366: 223-230.
178. Giles J. Beta-blockers tackle memories of horror. Nature 2005; 436: 448-449.
179. Liang KC, McGaugh JL, Yao HY. Involvement of amygdala pathways in the influence of post-training intra-amygdala norepinephrine and peripheral epinephrine on memory storage. Brain Res 1990; 508: 225-233.
180. Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature 1994; 371: 702-704.
181. Cahill L, Alkire MT. Epinephrine enhancement of human memory consolidation: Interaction with arousal at encoding. Neurobiol Learning Memory 2003; 79: 194-198.
182. Newell-Price J, Bertagna X, Grossman AB, Nieman L. Cushing's syndrome. Lancet 2006; in press.
183. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Rev 1998; 19: 647-672.
184. Starkman MN, Gebarski SS, Berent S. Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992; 32: 756-765.
185. Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 1999; 46: 1595-1602.
186. Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, Rawson E, Vaituzis AC, Stratakis CA, Chrousos GP. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005; 90: 2531-2536.
187. Brown ES, Suppes T. Mood symptoms during corticosteroid therapy: A review. Harvard Rev Psychiatry 1998; 5: 239-246.
188. Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 2002; 52: 386-392.
189. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurologica Scand 1996; 165: 3-112.
190. Marklund N, Peltonen M, Nilsson TK, Olsson T. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 2004; 256: 15-21.
191. Krugers HJ, Maslam S, Korf J, Joels M, Holsboer F. The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke 2000; 31: 1162-1172.
192. Edwards P, Arango M, Balica L, Cottingham R, El-Sayed H, Farrell B, Fernandes J, Gogichaisvili T, Golden N, Hartzenberg B, Husain M, Ulloa MI, Jerbi Z, Khamis H, Komolafe E, Laloe V, Lomas G, Ludwig S, Mazairac G, Munoz Sanchez Mde L, Nasi L, Olldashi F, Plunkett P, Roberts I, Sandercock P, Shakur H, Soler C, Stocker R, Svoboda P, Trenkler S, Venkataramana NK, Wasserberg J, Yates D, Yutthakasemsunt S. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005; 365: 1957-1959.
193. Goodyer IM, Park RJ, Netherton CM, Herbert J. Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology. Br J Psychiatry 2001; 179: 243-249.
194. Herbert J, Goodyer IM, Altham PM, Pearson J, Secher SM, Shiers HM. Adrenal secretion and major depression in 8- to 16-year-olds, II. Influence of co-morbidity at presentation. Psychol Med 1996; 26: 257-263.
195. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch General Psychiatry 2005; 62: 154-162.
196. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 2002; 16: 445-453.
197. Goodyer IM, Park RJ, Herbert J. Psychosocial and endocrine features of chronic first-episode major depression in 8-16 year olds. Biol Psychiatry 2001; 50: 351-357.
198. Angold A, Costello EJ, Erkanli A, Worthman CM. Pubertal changes in hormone levels and depression in girls. Psychol Med 1999; 29: 1043-1053.
199. de Kloet ER, Joels M, Holsboer F. Stress and the brain: From adaptation to disease. Nat Rev Neurosci 2005; 6: 463-475.
200. Meijer OC, Kalkhoven E, van der Laan S, Steenbergen PJ, Houtman SH, Dijkmans TF, Pearce D, de Kloet ER. Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 2005; 146: 1438-1448.
201. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 2005; 102: 19204-19207.
202. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. J Neurosci 2003; 23: 4850-4857.
203. Dallman MF. Fast glucocorticoid actions on brain: Back to the future. Front Neuroendocrinol 2005; 26: 103-108.
204. Roozendaal B. Stress and memory. Opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learnig Memory 2002; 78: 578-595.